Ligand validation:3TY9

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3TY9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TY9_AMP_C_900	66%	44%	0.159	0.966	0.95	1.27	1	1	1	0	100%	0.9565
3TY9_AMP_D_900	61%	44%	0.172	0.964	0.97	1.21	1	2	2	0	100%	0.9565
3TY9_AMP_A_900	61%	44%	0.17	0.961	0.92	1.3	1	2	1	0	100%	0.9565
3TY9_AMP_B_900	53%	45%	0.161	0.924	0.93	1.23	1	2	0	0	100%	0.9565
4E6N_AMP_C_902	84%	47%	0.117	0.988	0.9	1.14	1	2	1	0	96%	0.9565
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	42%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	42%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5NRH_AMP_B_700	99%	36%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1
4M0K_AMP_D_300	99%	41%	0.047	0.983	0.89	1.43	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.